Improvement in pain severity category in clinical trials of pregabalin

BACKGROUND: Pregabalin is approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM), diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN), and neuropathic pain due to spinal cord injury (SCI). Approval was based on clinical trial data demonstrating statisti...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Bruce, Argoff, Charles E, Clair, Andrew, Emir, Birol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063480/
https://www.ncbi.nlm.nih.gov/pubmed/27785092
http://dx.doi.org/10.2147/JPR.S102696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063480/
https://www.ncbi.nlm.nih.gov/pubmed/27785092
http://dx.doi.org/10.2147/JPR.S102696

Ejemplares similares